Kidney Disease Research Updates
NIDDK Director Rodgers Elected to Institute of Medicine
Griffin P. Rodgers, M.D., M.A.C.P., director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has been elected to the Institute of Medicine (IOM). Election to the IOM, one of the highest honors in the fields of health and medicine, recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
"It is a great pleasure to welcome these distinguished and accomplished individuals to the Institute of Medicine," said IOM President Harvey V. Fineberg, Ph.D., M.D. "Each of these new members stands out as a professional whose research, knowledge, and skills have significantly advanced health and medicine and who has served as a model for others."
Established in 1970 by the National Academy of Sciences, the IOM is recognized as a national resource for independent, scientifically informed analyses and recommendations on health issues. With their election, members make a commitment to volunteer their services on IOM committees and boards and participate in other IOM activities.
Dr. Rodgers was named NIDDK director on April 1, 2007. He had served as the NIDDK's acting director since March 2006 and was the deputy director from 2001 to 2009. Dr. Rodgers also has been chief of the Molecular and Clinical Hematology Branch since 1998; the branch is now administratively managed by the National Institutes of Health's National Heart, Lung, and Blood Institute. As a research investigator, Dr. Rodgers is widely recognized for his contributions to the development of the first effective-and now U.S. Food and Drug Administration-approved-therapy for sickle cell anemia.
NIH Publication No. 10-4531